Rallybio Corporation (RLYB) Analyst Estimates Quarterly

Rallybio Corporation

RLYB (NASDAQ)

(%)

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2026 12-30	2025 12-30	2025 09-30	2025 06-30	2025 03-30	2024 12-30	2024 09-30	2024 06-30
Number of Analysts	1234	3	3	1	1	4	2	5
Estimated Revenue
Low	1234	0.1	0.067	0.013	0.013	0.149	0.075	0.167
Average	1234	0.1	0.067	0.013	0.013	0.149	0.075	0.167
High	1234	0.1	0.067	0.013	0.013	0.149	0.075	0.167
Estimated EBITDA
Low	1234	0.06	0.04	0.008	0.008	0.09	0.045	0.1
Average	1234	0.06	0.04	0.008	0.008	0.09	0.045	0.1
High	1234	0.06	0.04	0.008	0.008	0.09	0.045	0.1
Estimated EBIT
Low	1234	0.06	0.04	0.008	0.008	0.09	0.045	0.1
Average	1234	0.06	0.04	0.008	0.008	0.09	0.045	0.1
High	1234	0.06	0.04	0.008	0.008	0.09	0.045	0.1
Estimated Net Income
Low	1234	-6.61	-9.61	-11.72	-11.72	-13.43	-18.06	-18.47
Average	1234	-6.61	-9.61	-11.04	-11.72	-12.95	-15.86	-16.86
High	1234	-6.61	-9.61	-10.36	-11.72	-12.47	-14.1	-14.86
Estimated SGA Expenses
Low	1234	0.697	0.464	0.093	0.093	1.04	0.523	1.16
Average	1234	0.697	0.465	0.093	0.093	1.04	0.523	1.16
High	1234	0.697	0.466	0.093	0.093	1.04	0.523	1.16
Estimated EPS
Low	1234	-1.17	-1.71	-2.08	-2.08	-2.39	-3.21	-3.28
Average	1234	-1.17	-1.71	-1.96	-2.08	-2.3	-2.82	-2.99
High	1234	-1.17	-1.71	-1.84	-2.08	-2.21	-2.5	-2.64

Market is Open